ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2032

Evaluation of RA Outcome Measures between Users and Non-Users of the Patient Portal

Sheryl Mascarenhas1, Shuvro Roy2, April Pinto2 and Preeta Gupta2, 1Rheumatology, The Ohio State University, Columbus, OH, 2The Ohio State University, Columbus, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Electronic Health Record, outcome measures and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Patient engagement has become a growing focus in healthcare, catalyzed with the passage of the Affordable Care Act in 2010.  Stage 2 of the Meaningful Use has criteria dependent on a patient portal, however whether electronic patient engagement translates into better clinical outcomes is yet to be determined.  To begin an evaluation into this we reviewed outcomes in rheumatoid arthritis patients who had signed up for the patient portal compared to those who did not.

Methods: Data was obtained from a retrospective chart review of rheumatoid patients seen at the Ohio State University Rheumatology Clinics.  The cohort included patients who had an ICD-9 or ICD-10 diagnosis consistent with rheumatoid arthritis.  Patient outcome measures including the most recent sedimentation rate (ESR), Rapid 3, and swollen joint count were recorded along with demographic data.  Two tailed t tests for these outcomes were done between each the group who had signed up for the patient portal and those that did not.

Results: 132 patients were included with 66 having signed up for the patient portal (Users) and 66 not signed up for the patient portal (Non-users).  103 (78.0%) of patients were female, with a mean age of 55 with a standard deviation of 13.79 years.  Outcome measures between the patients who signed up for the patient portal compared to those who had not 14.77 ±7.57 compared to 13.48 ±7.73 (p=0.33) for Rapid 3 scores, 1.97 ±2.25 compared to 2.86 ±4.06 (p=0.16) for swollen joint count, and 39.88 ±29.76 mm/hour compared to 30.61 ±22.04 mm/hour (p=0.04) for ESR.

Conclusion: To our knowledge this is the first study to examine whether electronic patient engagement is associated with a change in clinical outcomes in rheumatoid arthritis.  This initial study cohort does not demonstrate any clinically significant change in several key outcome measures in rheumatoid arthritis, particularly Rapid 3 scores, swollen joint counts.  However there was a statistical difference between the ESR, with more favorable values in patients using the patient portal.  This data suggests further study is needed to better understand if electronic patient engagement does have an effect on clinical outcomes in RA.

Table 1. Patient Demographics

Non-Users

Users

Total (n)

66

66

Age

58.7 (±14.79)

52.01(±11.77)

Female (%)

77.27%

78.70%

Race (n)

     White

41

53

     African American

16

7

     Hispanic

5

0

     Laotian

1

0

     Bengali

1

0

     Asian Indian

1

0

     Mexican

0

1

     Asian

0

1

     Middle Eastern

1

0

     Pakistani

0

1

     Unknown

0

1

     Other

0

2

Table 2. Outcome Measures between Users and Non-Users of the Patient Portal

Non-Users

Users

ESR

39.88 (±29.76)

30.61 (±22.04)

0.04

Swollen joint count

1.97 (±2.25)

2.86 (±4.06)

0.16

Rapid 3

14.77 (±7.57)

13.48 (±7.73)

0.33

 


Disclosure: S. Mascarenhas, None; S. Roy, None; A. Pinto, None; P. Gupta, None.

To cite this abstract in AMA style:

Mascarenhas S, Roy S, Pinto A, Gupta P. Evaluation of RA Outcome Measures between Users and Non-Users of the Patient Portal [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-ra-outcome-measures-between-users-and-non-users-of-the-patient-portal/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-ra-outcome-measures-between-users-and-non-users-of-the-patient-portal/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology